Innovative Data and Analytics Platform to Accelerate Drug Development for Rare Diseases

Launched by C-Path and NORD through an FDA grant, the goal of the new platform is to accelerate the development of cures by addressing the need to better characterize rare diseases.

TUCSON, Ariz. and WASHINGTON, September 19, 2019 — The Critical Path Institute (C-Path) and the National Organization for Rare Disorders® (NORD) launched the Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP) in Rockville, MD on Tuesday, Sept. 17. The platform, funded by a cooperative agreement through the Food and Drug Administration, [Critical Path Public-Private Partnerships Grant Number U18 FD005320], will provide data and analytics to aid in the understanding of rare diseases and to inform long-term drug development and support innovative trial designs.

Continue reading

Funded by FDA, C-Path and NORD to Launch Rare Disease Data Analytics Platform

The collaborative project between the organizations will kick off at a launch meeting in September and will aim to reduce barriers for the development of new treatments and cures for rare diseases 

TUCSON, Ariz. and WASHINGTONAugust 7, 2019  The Critical Path Institute (C-Path) and the National Organization for Rare Disorders® (NORD) will host a meeting on Tuesday, September 17 in Bethesda, MD to formally launch development of a new rare disease data and analytics platform. Funded by a cooperative agreement through the Food and Drug Administration, [Critical Path Public-Private Partnerships Grant Number U18 FD005320 from the US Food and Drug Administrationthe goal of the platform is to accelerate the movement of therapies from bench to bedside for rare diseases. The platform will provide the infrastructure for a sustainable, cooperative scientific approach to clinical trial readiness in rare diseases by addressing vast knowledge gaps about the natural course of disease, the clinical evaluation of new treatments, and patients perspective on disease and treatment. 

Continue reading

Graduate Certificate Program in Regulatory Science Offered by UA Colleges of Law and Pharmacy and the Critical Path Institute Now Accepting Applications

Designed for graduate students and working professionals, the certificate program provides specialized training in navigating the path from research to bringing medical products to market.

TUCSON, Ariz., July 16, 2019 — The University of Arizona and the Critical Path Institute are urging students and working professionals to apply now for acceptance into their new online graduate certificate program designed to equip participants across multiple disciplines with core competencies in regulatory science. Regulatory science is the science of developing new tools, standards and approaches to assess the safety, efficacy, quality and performance of all products regulated by the U.S. Food and Drug Administration (FDA).

Continue reading

C-Path Taps Medical Science Operations Executive Kristen Swingle as Chief Operating Officer

TUCSON, Ariz., July 2, 2019 The Critical Path Institute (C-Path) is pleased to announce that after an extensive search, it has appointed Kristen Swingle as its new Chief Operating Officer, effective July 1, 2019.

Swingle, who previously served as Vice President of Stem Cell Operations for Cord Blood Registry (CBR), a part of California Cryobank Life Sciences, specialized in newborn stem cell collection, processing and cryopreservation, brings nearly two decades’ worth of experience in the medical and molecular sciences industry to bear in her new role as she leads the daily operations of the organization and development and implementation of C-Path’s global strategy and goals.

Continue reading

MIHS, Dignity Health, others form new health education alliance

Maricopa Integrated Health System (MIHS), Creighton University School of Medicine, Dignity Health St. Joseph’s Hospital and Medical Center, and District Medical Group, Inc., have announced a new alliance aimed at increasing the number of doctors and other health professionals in Arizona in order to meet the state’s growing demand for physicians and other healthcare professionals.Continue reading

VisionGate Hires Renowned Chief Medical Officer Dr. Javier Zulueta

PHOENIX, Ariz. (June 2, 2016) – VisionGate, Inc. today announced the appointment of Dr. Javier Zulueta as its Chief Medical Officer. A world-renowned pulmonologist, professor and 16-year Director of Pulmonary Service at the University Clinic of Navarra, the teaching hospital of Spain’s University of Navarra School of Medicine, Dr. Zulueta will provide expert counsel and oversight of VisionGate’s clinical collaborations and associated clinical trials in lung cancer early detection and chemoprevention therapy.Continue reading